ClinicalTrials.gg
RecruitingNCT07498452Updated Mar 27, 2026

Unmet Needs Among Patients With Isolated REM Sleep Behavior Disorder (iRBD) and Their Significant Others

An observational study in REM Sleep Behavior Disorder and Isolated REM Sleep Behavior Disorder, sponsored by Universita di Verona. Recruiting at 8 sites in Italy. Per ClinicalTrials.gov, last updated 2026-03-27.

Sponsored by Universita di Verona · Observational

How we know

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started May 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
150
Sex
All
01

Study summary

The goal of this observational study is to explore the unmet needs and the psychosocial impact of isolated REM Sleep Behavior Disorder (iRBD) on patients and their significant others. Isolated REM Sleep Behavior Disorder is a sleep disorder characterized by dream-enactment behaviors during REM sleep and is increasingly recognized as a prodromal condition associated with neurodegenerative diseases. Despite growing clinical attention, little is known about the informational, emotional, and practical needs experienced by patients and their caregivers.

The main questions this study aims to answer are:

What are the main unmet informational, psychological, and clinical needs reported by patients with isolated REM Sleep Behavior Disorder?

What are the main challenges and support needs experienced by their significant others or caregivers?

How does the diagnosis of iRBD affect quality of life, emotional well-being, and perceptions of future health risks for both patients and caregivers?

This is a multicenter cross-sectional observational study conducted in several sleep and movement disorders centers. The study aims to collect structured information directly from patients and their significant others in order to better understand their experiences, concerns, and expectations regarding the disease and its management.

Participants will be asked to:

complete an online questionnaire about their experience with isolated REM Sleep Behavior Disorder, including perceived needs, access to information, and interactions with healthcare services;

report information about emotional well-being, quality of life, and concerns related to the possible future progression of the disorder;

caregivers or significant others will complete a parallel questionnaire focused on their experiences, caregiving burden, informational needs, and perceived support.

The information collected in this study will help clinicians and researchers better understand the real-world needs of individuals living with isolated REM Sleep Behavior Disorder and their families. The results may contribute to improving patient education, clinical care pathways, and support services for this population.

Read the detailed description

Isolated REM Sleep Behavior Disorder (iRBD) is a parasomnia characterized by the loss of normal REM sleep atonia and the presence of dream-enactment behaviors. Over the last two decades, increasing evidence has shown that iRBD represents one of the strongest clinical prodromal markers of synucleinopathies, including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. As a consequence, individuals diagnosed with iRBD often face uncertainty and psychological distress related to the potential future development of neurodegenerative disease.

Despite growing scientific and clinical interest in iRBD, relatively little attention has been dedicated to the experiences, informational needs, and psychosocial burden associated with the diagnosis, both for patients and for their significant others or caregivers. Understanding these aspects is essential for improving patient-centered care, communication strategies, and support services.

The present study is a multicenter cross-sectional observational study designed to investigate the unmet needs, perceived challenges, and psychosocial impact associated with iRBD. The study involves several sleep and movement disorders centers and aims to collect structured data from individuals diagnosed with iRBD and from their significant others.

Participants will complete structured questionnaires administered through an online survey platform. The questionnaires collect information on multiple domains, including disease-related knowledge, perceived informational needs, interactions with healthcare services, emotional well-being, quality of life, and concerns about disease progression. Significant others or caregivers will complete a parallel questionnaire addressing caregiving experiences, perceived burden, informational needs, and support resources.

The data collected in this study will provide important insights into the real-world experiences of individuals living with iRBD and their families. The results may contribute to the development of targeted educational resources, improved clinical communication strategies, and support interventions aimed at addressing the unmet needs of this population.

02

Conditions studied

  • REM Sleep Behavior Disorder
  • Isolated REM Sleep Behavior Disorder

Keywords

  • iRBD
  • REM Sleep Behavior Disorder
  • Prodromal Parkinsonism
  • Patient Needs
  • Sleep Disorders
03

In context

REM Sleep Behavior Disorder

101 studies on the registry are indexed under REM Sleep Behavior Disorder; 45 are open to participants now.

This study's planned enrollment of 150 is close to the median of 138 across 48 observational studies indexed under REM Sleep Behavior Disorder.

Browse REM Sleep Behavior Disorder studies →

Lead sponsor

Universita di Verona is the lead sponsor of 125 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults diagnosed with isolated REM Sleep Behavior Disorder (iRBD) recruited at participating sleep and movement disorders centers, and their significant others or caregivers. Patients are identified during routine clinical care and invited to participate in the study together with a family member or significant other. Both patients and caregivers complete structured questionnaires assessing informational needs, psychosocial impact, and experiences related to the diagnosis and management of iRBD.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients diagnosed with iRBD according to the International Classification of Sleep Disorders, 3rd Edition (ICSD-3) criteria.
  • Patients who have had a follow-up visit within the previous 12 months.
  • Patients who provide to participate in the study.
  • Partners/family members of patients with iRBD who accept to participate.

Exclusion criteria

Exclusion Criteria:

  • Patients with RBD who have already phenoconverted to a neurodegenerative disorder.
  • Patients or partners/family members without access to an email address.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with isolated REM Sleep Behavior Disorder

    Individuals diagnosed with isolated REM Sleep Behavior Disorder who participate in the study by completing an online questionnaire assessing informational needs, psychosocial impact, quality of life, and experiences related to the diagnosis.

  • Caregivers or significant others of patients with isolated REM Sleep Behavior Disorder

    Caregivers or significant others of patients with isolated REM Sleep Behavior Disorder who complete a parallel questionnaire, informational needs, and perceived support.

06

What researchers measure

Primary outcomes

  1. Unmet informational, clinical, and psychosocial needs in patients with isolated REM Sleep Behavior Disorder and their significant others

    Assessment of unmet informational, clinical, and psychosocial needs in individuals diagnosed with isolated REM Sleep Behavior Disorder and in their significant others using a structured online questionnaire administered in participating centers. The questionnaire explores domains including disease-related knowledge, access to information, interactions with healthcare services, perceived support needs, emotional well-being, and concerns about future disease progression.

    Time frame: Baseline (single assessment at questionnaire completion)

Secondary outcomes

  1. Identification of areas for improvement in healthcare services and informational resources for patients with isolated REM Sleep Behavior Disorder

    Identification of areas where patients with isolated REM Sleep Behavior Disorder and their significant others report unmet needs related to healthcare services, access to information, clinical communication, and support resources, based on responses to structured survey questions administered during the study.

    Time frame: Baseline (single assessment at questionnaire completion)

07

Study locations

8 of 8 sites recruiting
08

References and documents

Publications

  • Perez-Carbonell L, Simonet C, Chohan H, Gill A, Leschziner G, Schrag A, Noyce AJ. The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure. Mov Disord. 2023 Jun;38(6):1089-1093. doi: 10.1002/mds.29403. Epub 2023 Apr 12. PubMed 37046409 ↗
  • Gossard TR, Teigen LN, Yoo S, Timm PC, Jagielski J, Bibi N, Feemster JC, Steele T, Carvalho DZ, Junna MR, Lipford MC, Tippmann Peikert M, LeClair-Visonneau L, McCarter SJ, Boeve BF, Silber MH, Hirsch J, Sharp RR, St Louis EK. Patient values and preferences regarding prognostic counseling in isolated REM sleep behavior disorder. Sleep. 2023 Jan 11;46(1):zsac244. doi: 10.1093/sleep/zsac244. PubMed 36259668 ↗
  • Ingravallo F, D'Alterio A, Rossetti A, Antelmi E, Plazzi G. Disclosing the Risk Associated with Isolated REM Behavior Disorder: The Sleep Experts' Perspective. Mov Disord Clin Pract. 2024 May;11(5):488-495. doi: 10.1002/mdc3.13998. Epub 2024 Feb 11. PubMed 38341655 ↗
  • Mahmood Z, Van Patten R, Nakhla MZ, Twamley EW, Filoteo JV, Schiehser DM. REM Sleep Behavior Disorder in Parkinson's Disease: Effects on Cognitive, Psychiatric, and Functional outcomes. J Int Neuropsychol Soc. 2020 Oct;26(9):894-905. doi: 10.1017/S1355617720000430. Epub 2020 May 7. PubMed 32375913 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2025 (actual). Primary completion is estimated for May 2026, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 18, 2026
First posted
Mar 27, 2026
StartActual
May 6, 2025
Primary completionEst.
May 2026
CompletionEst.
Aug 2026
Last update
Mar 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07498452
Responsible party
Elena Antelmi (Principal Investigator, Universita di Verona) — Principal investigator
First posted
Mar 27, 2026
Start date
May 6, 2025
Primary completion
May 2026 (estimated)
Completion
Aug 2026 (estimated)
Last update
Mar 27, 2026

Study contacts

Elena Antelmi, Md, PhD
Contact
elena.antelmi@univr.it
+39 0458124290
Giacomo Carollo, MSc
Contact
giacomocarollo.2@gmail.com

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion